As I described in more detail here (and see a thorough dissenting statement from Commissioner Melissa Holyoak on the decision to issue the 2024 report), the interim staff report was sorely lacking in systematic analysis of the data collected in the commission’s 6(b) study, and in findings about drug prices that could be tied to PBM practices. [read post]

Those who took the time and made the effort to nominate their personal recommendations for Blawg Review of the Year 2009 know how daunting a task it is to single out a half dozen outstanding presentations of Blawg Review in 2009. [read post]